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Abstract Actin-crosslinking proteins link F-actin into the bun- 
dles and networks that constitute the cytoskeleton. Dystrophin, 
/]-spectrin, ce-actinin, ABP-120, ABP-280, and fimbrin share ho- 
mologous actin-binding domains and comprise an actin 
crosslinker superfamily. We have identified a novel member of 
this superfamily (ACF7) using a degenerate primer-mediated 
PCR strategy that was optimized to resolve less-abundant super- 
family sequences. The ACF7 gene is on human chromosome 1 and 
hybridizes to high molecular weight bands on northern blots. 
Sequence comparisons argue that ACF7 does not fit into one of 
the existing families, but represents a new class within the super- 
family. 
Key words: Actin-binding protein; Multigene family; 
Polymerase chain reaction; Human brain; Dystrophin; 
fl-Spectrin 
1. Introduction 
ABP-280 expression can reverse motility defects in a human cell 
line lacking ABP-280 [8]; loss of ABP-120 has been shown to 
disrupt motility in Dictyostelium amoebae [9]; and mutations in 
the yeast fimbrin gene lead to defects in cytoskeletal organiza- 
tion and cellular morphogenesis [10]. 
We are seeking to identify additional members of this super- 
family on the hypothesis that they are candidates for involve- 
ment in other hereditary disorders [1 I]. In previous tudies, a 
protein with overall structural similarity to dystrophin, called 
utrophin or dystrophin-related protein, was identified by a 
DNA hybridization approach [12,13]. Past efforts in our labo- 
ratory using PCR amplification with degenerate primers re- 
suited in the description of two new isoforms of human c~- 
actinin [14]. However, the c~-actinin transcripts were present in 
relatively high abundance, and we had difficulty identifying 
additional superfamily members that might have been present 
in lower amounts. Here we describe a novel member of this 
actin crosslinker superfamily identified by an enhanced degen- 
erate primer-mediated PCR strategy. 
The actin cytoskeleton is central to cellular structure and 
motility; it provides tability or plasticity according to the needs 
of the cell. The organization of the actin cytoskeleton is regu- 
lated by a diverse group of proteins, including ones that 
crosslink actin filaments into bundles or networks. There are 
several families of actin-crosslinking proteins, and sequence 
analysis has revealed a homologous actin-binding domain in a 
large subset, referred to as the fimbrin, c~-actinin, filamin family 
[1], or as an actin crosslinker superfamily ([2], also see [3]). This 
domain is found in members of the spectrin superfamily (fl- 
spectrin, ~-actinin, and dystrophin), and in ABP-280 (filamin), 
ABP-120 (gelation factor), as well as in fimbrin (plastin). Re- 
cent data suggest that the actin-binding domains of superfamily 
members are functionally homologous as well, and bind to the 
same sites on actin [3]. Despite homology in the actin-binding 
region, however, the proteins in these families serve distinct 
functions, range in size from 70 to 423 kDa and differ greatly 
in such basic features as their overall secondary structure 
[1,2,4]. 
Proteins of this actin crosslinker superfamily have proven to 
be important in hereditary diseases. Defects in dystrophin are 
responsible for the Duchenne and Becker muscular dystrophies 
[5], and defects in spectrin give rise to hereditary hemolytic 
anemias [6]. In addition, mutations in the ~-actinin gene of 
Drosophila cause muscle weakness, paralysis, and atrophy [7]; 
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2. Materials and methods 
2.1. Primers and template DNA 
Mixtmes of oligonucleotides (degenerate primers) were designed 
from two conserved regions identified in sequence alignments of the 
actin-binding domains of actin crosslinker superfamily members. Be- 
cause of considerable s quence divergence b tween superfamily mem- 
bers, it was necessary to limit the complexity in each mixture (i) by 
arbitrarily omitting some of the combinations ecessary toencode all 
of the known superfamily members, and (ii) by using inosine (I) in some 
positions where maximal degeneracy was desired [l5,16]. Each reaction 
employed a degenerate antisense primer eferred to as 'WTIILR' (cor- 
responding to dystrophin amino acid residues 542 559) that adds a 
NotI site to the product (underlined), [GCGGAGCGGCCGCI(C/ 
T)(G/T)IA(A/G) (A/G/T) ATIA(A/G/T)I(G/T)TCCA]; and either a 
non-degenerate 2gtl0 primer near the polylinker, [GCCGTCGACTT- 
GAGCAAGTTCAGCCTGGTT]; or a degenerate s nse primer re- 
ferred to as 'KTFTKW' (corresponding to dystrophin amino acid res- 
idues 261-280) that also adds a NotI site, [GGGGTGGCGGCCGC- 
AGAA(A/G)AC(A/C/G/T)TT(CIT)AC(A/C/G/T) (A/G)(A/C)(A/G/C/ 
T)TGG]. Lambda phage DNA was prepared from an oligo-dT-primed 
human fetal brain cDNA library in 2gtl0 [17] for use as template DNA 
in PCR amplification reactions. The library was amplified by plate 
lysate, phage were purified by PEG precipitation and cesium chloride 
gradient centrifugation, and DNA was isolated according to Sam- 
brook, et al. [18], 
2.2. Two-step PCR with degenerate primers 
The PCR reactions (50 ¢tl per reaction, 4reactions) included 5ng/ktl 
template DNA (2,gt 10 library DNA containing cDNA inserts as above), 
primers (0.4 ¢tM degenerate primer(s) or 0.2 ¢tM 2gtl0 primer as indi- 
cated below), 10 mM Tris-HC1 (pH 9), 50 mM KC1, 1.5 mM MgC12, 
and 0.001% gelatin. This mixture was incubated at 98°C for 5 rain, then 
was brought down to 80°C for the addition of 0.2 mM each of dATE 
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dCTP, dGTP, dTTP, plus 0.025 units//.tl Taq polymerase (Pharmacia). 
The mixture was then cycled (94°C, 30 s; 53°C, 4 rain; 72°C, 4 min) 
27 times. The first PCR step was carried out with the 2gtl0 and 
WTIILR primers. The products were precipitated with ethanol, resus- 
pended, and separated on one lane of a 1.75% low-melting point aga- 
rose gel (NuSieve, FMC). Many bands were observed after the first 
amplification, and the region between 300 bp and 4,000 bp was sliced 
into 19 fractions (of roughly 50-200 pl per fraction) to separate major 
and minor bands. In the second PCR step, 0.5 ktl of each melted gel slice 
was used as template DNA for 30 cycles of amplification i a 15/tl 
reaction volume with the KTFTKW and WTIILR primers (same con- 
ditions as above, except hat the 72°C elongation step was for 1 min). 
This amplification was repeated after transferring 1 ¢tl of the first 
amplification reaction into 50/tl of fresh reaction mix. The final reac- 
tion product was precipitated and electrophoresed on an agarose gel as 
above. Bands in the 300-400 bp range were excised from the gel, eluted 
using the Magic PCR Prep procedure (Promega Corp.), digested with 
NotI, and ligated into NotI-cut pBluescript SK II+ (Stratagene). White 
colonies were chosen by blue/white selection on X-Gal plates and DNA 
sequence was determined for subclones with inserts in the 300-400 bp 
range. Once the new actin-binding domain PCR product had been 
identified, it was labelled by PCR amplification i the presence of 10 
/.tCi of [ct-32p]dCTP and was used for ahybridization screen of the same 
library used to prepare the template DNA for the cloning of additional 
cDNA's. 
2.3. Sequence analysis 
DNA sequence determination was carried out either manually using 
a Sequenase kit (United States Biochemical) or on an Applied Biosys- 
terns Inc. 373A sequenator. The DNA sequences of PCR products were 
used to conduct database homology searches at the National Center for 
Biotechnology Information using the BLAST network service [19]. 
DNA Sequences were analyzed using the Wisconsin Genetics Com- 
puter Group package [20]. The nucleotide sequence reported in this 
paper has been submitted to the GenBank/EMBL Data Bank with 
accession umber L40626. 
2.4. Northern blot analysis 
32p-labelled DNA probes were prepared by PCR amplification i the 
presence of 10/tCi of [~-32p]dCTP in the place of unlabelled CTE 
Multi-tissue Northern blots containing 2 ¢tg poly A + RNA from human 
tissues (Clontech) were hybridized according to the manufacturer's 
instructions. 
2.5. Chromosome mapping 
Southern blots containing HindIII digested DNA from a panel of 
nine human/hamster somatic ell hybrids [21] were screened by hybrid- 
ization. In addition, selected monochromosomal human/rodent hybrid 
DNAs were amplified by PCR as described [22] and were separated on 
SSCP gels to distinguish t e human PCR product from the homologous 
rodent locus [23]. 
3. Results 
3.1. Strategy 
The first amplification step utilized a primer corresponding 
to 2,gtl0 vector sequence and an antisense actin-binding do- 
main degenerate primer (WTIILR). The template was bacterio- 
phage DNA purified from a ~gt 10 human brain eDNA library. 
The first step amplification products were gel fractionated in 
an attempt to achieve size resolution between different superfa- 
mily members by virtue of the distinctive 5' end lengths of each 
family member. Some loss of size resolution was anticipated 
due to amplification of cDNA inserts that were not full length 
at their 5' ends. This fractionation step allowed us to reduce the 
effects of competition by high abundance sequences such as
fl-spectrin and ct-actinin. The second amplification step utilized 
a second actin-binding domain degenerate sense primer 
(KTFTKW) not used in the first round, along with the 
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Fig. 1. Summary diagram of eDNA sequences. The ACF7 PCR prod- 
uct is shown on the top line with arrows representing the degenerate 
primers. The open box shows the region with homology to the actin 
crosslinker superfamily utilized for the sequence alignment in Fig. 2. 
The shaded bars show the extent of the probes used for northern blot 
hybridizations (bases 49-532 and 732-1026). The number 1 indicates 
the start of the region of exact match between library subclones B6-3 
and B2-19, and the start of base pair numbering. The 'AA' indicates 
that each of these clones ended in a series of A residues (see text). 
ent primer sets greatly increased the yield of superfamily cDNA 
clones as compared with two 30-cycle rounds of amplification 
containing the same two degenerate primers (not shown). In 
addition, because the spacing between these two primer sites is 
300400 bp in all known family members, the final PCR prod- 
ucts were gel fractionated to select bands in this size range for 
further analysis. 
3.2. Results of the two-step degenerate primer-mediated PCR 
screen 
We sequenced eDNA inserts of 61 randomly selected PCR 
subclones from 14 of the 19 fractions, and used the sequences 
to search the GenBank database. Of these, 22 matched fl-spec- 
trin, 8 were a-actinin eDNA's, and one eDNA encoded a novel 
protein with homology to the actin crosslinker superfamily 
(referred to as ACF7). Thirty PCR subclones did not show 
sequence similarity with the actin-binding domain of the actin 
crosslinker superfamily. Thus, 51% of the PCR subclones were 
specifically amplified from sequences encoding the expected 
actin-binding domains. Dystrophin eDNA clones were not re- 
covered because they had been depleted in a previous creening 
and amplification of this library. 
It was expected that a given transcript would tend to have 
the same length of 5' sequence, and would cluster in a few 
fractions from the first gel fractionation. This was the general 
trend; fl-spectrin cDNA's were found primarily in fractions 
originating from the top portion of the gel (10 of 11 PCR 
subclones from fractions 2 and 3 were fl-spectrin). Similarly, all 
of the ~-actinin cDNA's originated from slices in the bottom 
half of the gel, with 5 out of the 8 c~-actinin subclones in fraction 
19. The ACF7 eDNA was identified in fraction 5. 
3.3. Analysis of library subclones 
The ACF7 PCR product was labelled with 32p and used as 
a probe to screen the original cDNA library. Six positive clones 
were isolated, and phage DNA was purified and digested with 
EcoRI. The digests were blotted to nitrocellulose paper and 
probed with the ACF7 PCR product. One EcoRI fragment was 
positive from each clone, and three positive-hybridizing frag- 
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Fig. 2. Alignment of the ACF7 predicted amino acid sequence with consensus sequences from ach actin crosslinker family. All of the peptide 
sequences listed below were aligned in the region of similarity with the PILEUP program. Gapped sequences written by the PILEUP program were 
used by the PRETTY program to generate consensus sequences of identical residues for each family (the number of family members used for each 
consensus appears in parentheses). Consensus residues that match the ACF7 sequence are shaded. Spaces indicate gaps introduced by the PILEUP 
program, and dashes indicate non-consensus residues within each family. B rsindicate the positions of the degenerate primers. Note that w  have 
grouped ABP280 and ABP120 to form a consensus because they have structural similarities, but they are very different in size and may also be 
considered as two separate families. The sequences for each family were as follows (GenBank accession number and residue numbers in parentheses): 
'ACF7', New actin-crosslinker: human (L40626; 80-292); 'DYS', dystrophin family: human (X14298; 17-234), mouse (M68859; 17-234), chicken 
(X13369; 21~38), and human utrophin (X69086; 33-249); 'ACT', ~-actinin family: human ACTN1 (M95178; 33-244), ACTN2 (M86406; 40-251), 
ACTN3 (M86407; 47 258), Chicken (J03486; 34-245) and (X13874; 43-254), D. diseoideum (Y00689; 24-237), and D. melanogaster (X51753; 36-247); 
'BSP', fl-spectrin family: human (J05500; 56-272), mouse (M74773; 56-272), D. melanogaster (M92288; 52-268), and (X53992; 26-246); 'ABP' family: 
human ABP280/filamin (X53416; 45-263), and D. discoideum ABP120/gelation factor (X15430; 14-221); 'FIM', fimbrin/plastin family: human 
I-plastin (L20826; 124-370), L-plastin (M22299; 65 312), and T-plastin (M22300; 65-312), rat T-plastin (X70706; 122-369), S. cerevisiae fimbrin 
(X63867; 141-384), and chicken fimbrin (X52562; 124-370). 
ments of different sizes were subcloned into pBluescript SK II+ 
for further analysis. The largest positive-hybridizing EcoRI 
fragment, B6-3, was sequenced entirely on both strands. The 
entire length of B6-3 was open reading frame, ending in a 
stretch of A residues without a stop codon or polyadenylation 
signal, indicating the likelihood of aberrant priming at an inter- 
nal series of A residues in the reverse transcription step of 
library construction. Clones B1-3 and B2-19 were sequenced 
at their ends. They both matched B6-3 exactly at their 3' ends, 
also ending in a series of A residues (Fig. 1). At their 5' ends, 
B2-19 and B6-3 began to match identically at base 67 of B6-3 
and base 24 of B2-19. Because the short region of mismatch 
at the 5' end of these clones may signal that one of them is a 
cloning artifact, we have designated the starting point of iden- 
tical match as base 1 and we have submitted the sequence from 
l-1157 to the GenBank/EMBL Data Bank. The 5' end of B1-3 
was identical with B6-3 beginning at base 501. For the purposes 
of this work, we have designated the first methionine (at base 
52) in our open reading frame as residue l of the predicted 
amino acid sequence. 
were consistently lower than comparisons between family mem- 
bers, even when highly divergent sequences from lower eukar- 
yotes were included in the analysis (Table 1). These data pro- 
vide evidence that the ACF7 product is a new class (and possi- 
bly a new family) within the actin crosslinker superfamily. 
3.5. Analysis of expression 
Northern blot hybridization revealed multiple high molecu- 
lar weight bands after long exposure (data not shown). Though 
the bands were faint and not well resolved, they were reproduc- 
ible in two independent blots. The bands were substantially 
larger than the 9 kb molecular weight marker and appeared to 
be larger in size than the dystrophin transcript (14 kb); we 
estimate them to be in the range of 14-20 kb. The highest signal 
strength was observed in lung, brain, liver and kidney, followed 
by pancreas, skeletal muscle, and heart, with the lowest level 
in placenta. Similar results were obtained on duplicate blots 
with each of the two probes diagrammed in Fig. l. 
3.4. Sequence comparisons 
To analyze relations between ACF7 and the homologous 
N-terminal regions of members of the actin crosslinker superfa- 
mily, we aligned the predicted amino acid sequence of ACF7 
with consensus sequences of each family. The consensus se- 
quences in Fig. 2 consist of residues that are identical in every 
available member of each family. As shown in Fig. 2, the ACF7 
sequence matches many residues in each family consensus. 
There are also many positions that differ from each family. For 
each family consensus, there are positions that do not match 
ACF7, while another family does match at the same position, 
thus there is no one family whose consensus consistently agrees 
with ACF7. In addition, pairwise comparisons between ACF7 
and the amino-terminal domains of the members of each family 
Table 1 
Pairwise sequence comparisons of ACF7 and actin-crosslinkers 
Family ACF7 vs. each  Minimum match 
family member within family 
Dystrophin 49-51% 72% 
a-Actinin 46-53% 64% 
fl-Spectrin 52 60% 75% 
ABP 120/ABP280 26-28 % 41% 
Fimbrin/plasfin 39~,2% 46% 
The predicted amino acid sequence ofACF7 was compared with each 
actin crosslinker superfamily member (sequences as in Fig. 2) using the 
GAP program. The range of percentage identity for each family is listed 
in the first column. Pairwise comparisons were also carried out between 
the members of each family. The comparison that gave the minimum 
percent identity within each family appears in the second column. 
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Table 2 
Segregation fACF7 a with human chromosomes in DNA from somatic 
cell hybrids 
Chromosome Hybridization pattern b Discordant 
fraction ° 
+/+ - / -  +/- -/+ 
1 1 8 0 0 0.00 
2 0 5 0 2 0.28 
3 1 4 0 3 0.38 
4 0 5 1 2 0.38 
5 1 5 0 3 0.33 
6 1 4 0 3 0.38 
7 0 4 1 4 O.56 
8 0 3 1 5 0.67 
9 0 6 1 2 0.33 
10 0 4 0 3 0.43 
11 1 5 0 2 0.25 
12 1 4 0 3 0.38 
13 1 5 0 3 0.33 
14 1 3 0 4 0.50 
15 1 7 0 1 0.11 
16 1 3 0 5 0.56 
17 0 5 1 3 0.44 
18 0 4 1 4 0.56 
19 and 19der d 1 1 0 7 0.78 
20 1 1 0 7 0.78 
21 1 4 0 4 0.44 
22 1 5 0 3 0.33 
X 1 6 0 1 0.13 
Y 0 8 1 0 0.11 
a The hybridization probe was 32p-labelled B6-3 cDNA. 
b Number of hybrids with indicated pattern of hybridization signal and 
chromosome. +/+ = hybridization signal and chromosome both pres- 
ent; - / -  = hybridization signal and chromosome both absent; +/- = 
hybridization present but chromosome absent; -/+ -- hybridization 
absent but chromosome present. 
c Hybrids with a rearranged chromosome or in which the chromosome 
was present in fewer than 15% of cells were excluded for calculation of 
discordant fractions. 
aThis includes nine hybrids containing the der 19 translocation chro- 
mosome 19pter-q13::Xq24-qter and one hybrid containing 19qter- 
p13 ::Xql3-qter. 
3.6. Human chromosomal locus 
A human/hamster somatic cell hybrid mapping panel was 
screened by hybridization with B6-3. A single, predominant 
hybridizing HindIII fragment was present in control human 
DNA and in hybrid D4, but not in control hamster DNA (data 
not shown). Segregation analysis suggested that ACF7 is on 
chromosome 1 (Table 2). To confirm this, sequences corre- 
sponding to bases 78-280 of B6-3 were amplified by PCR from 
several independent mono- and dichromosomal hybrids [22]. 
The human sequence was present in a human/hamster hybrid 
that contained only human chromosomes 1 and X on a hamster 
background, and was not present in a hybrid that contained 
only the human x chromosome (data not shown). This con- 
firms chromosome 1 as the location of the human ACF7 gene. 
4. Discussion 
Here we describe the actin-binding domain of a new actin 
crosslinker superfamily member. ACF7 maps as a single, novel 
locus on human chromosome 1.Sequence comparisons indicate 
that ACF7 does not fall into the existing family groupings, and 
probably represents a new class within this actin crosslinker 
superfamily. In the region of comparison, ACF7 bears the most 
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similarity to fl-spectrin, followed by ~-actinin and dystrophin, 
with the least similarity to ABP120, ABP280, and fimbrin. 
Expression of the ACF7 gene appears to give rise to a set of 
very large transcripts that show different tissue specificities, 
indicating the possibility of differential splicing and/or multiple 
promoters. Both of these mechanisms work in the dystrophin 
gene to give isoforms that differ dramatically in size [13,24]. It 
is apparent from the transcript size that considerable cloning 
remains to be done to isolate cDNA for, and to determine the 
complete ACF7 sequence. 
Many variations of degenerate primer-mediated PCR have 
been used to isolate DNA sequences of related genes based on 
conserved regions of amino acid homology (see [25-27] for 
examples). Here we present a modified strategy to be tried in 
the event that a more straightforward approach fails to yield 
an adequate signal-to-noise ratio. The use of different primer 
sets in two PCR amplification steps increased the specificity 
and resulted in a high yield of superfamily members, while gel 
fractionation after the first amplification step accomplished a 
degree of discrimination between superfamily members, allow- 
ing the detection of ACF7, a lower abundance form. 
Each family of this actin-crosslinker superfamily has a very 
distinctive and modular structure [1,2,4]. These distinctive fea- 
tures provide for variability in the length and rigidity of the 
crosslink, determining whether actin filaments are organized 
into tight bundles or loose gels. The only feature shared be- 
tween all families is the actin-binding domain. It appears that 
these sequences have served as an evolutionary cassette to con- 
fer actin-binding activity to otherwise very different proteins. 
The product of the high molecular weight ACF7 transcripts 
may be a very large protein with a modular structure such as 
dystrophin, titin, or nebulin. Further analysis of the ACF7 gene 
and protein should give additional insight into its function as 
well as the evolutionary elations and structural diversity of this 
superfamily of actin binding and crosslinking proteins. 
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